Navigation Links
Preliminary agenda available for 4th VEINS Conference to be held October 9-12 in Chicago
Date:7/24/2014

A preliminary agenda for the 4th Annual National Venous Interventional Summit is available at: http://theveins.org/agenda/agenda.

VEINS is an established Venous Endovascular Interventional Strategies group comprised of experts in the field whose primary aim is to provide a "How To" meeting for cardiologists and other healthcare providers who are interested in advancing their knowledge and skills in venous interventions and whose ultimate goal is developing their own comprehensive venous interventional program. Topics at this year's meeting will include:

  • VEINS 101
  • New Trials and Continued Controversies
  • Superficial Venous Disease, Medical Therapy, and Wound Management
  • Medical Therapy
  • Deep Venous Disease and Device Therapy
  • Acute Deep Vein Thrombosis
  • Endovascular Treatment of Iliofemoral Chronic Post Thrombotic Venous Flow Obstruction
  • Contemporary Management of Pulmonary Embolism
  • Venous Chronic Total Occlusions
  • Inferior Vena Cava Filters
  • Vascular Potpourri Case-Based Session

VEINS 2014 is the premier national venous meeting for cardiologists of all specialties providing comprehensive education for the treatment of patients with venous disease. The conference will feature cutting-edge and future strategies for venous treatment and several fast-paced didactic lectures, given by a multidisciplinary group of physicians who are experienced in developing venous programs. Sessions will highlight real-world experience and allow for multiple opportunities for attendee and faculty interaction. Additional highlights include hands-on breakout sessions, industry symposia, and case reviews.

VEINS (Venous Endovascular InterveNtional Strategies) is a multi-disciplinary group of physicians who have an interest in all aspects of venous disease and a deep commitment to education. The program is targeted to cardiologists and other health professionals such as vascular medicine specialists, vascular surgeons, radiologists, cardiology fellows, registered vascular technologists, and registered nurses.

Course Directors

Raghu Kolluri, MD, FSVM, FSCAI
OhioHealth and Riverside Methodist Hospital
Columbus, OH

Gregory Mishkel, MD, FSVM, FSCAI
Prairie Cardiovascular Consultants, Ltd.
Springfield, IL

Associate Directors

Gary M. Ansel, MD, FSVM, FSCAI
OhioHealth and Riverside Methodist Hospital
Columbus, OH

Jeffrey A. Goldstein, MD, FSCAI
Prairie Cardiovascular Consultants, Ltd.
Springfield, IL

Nilesh Goswami, MD, FSVM, FSCAI
Prairie Cardiovascular Consultants, Ltd.

Nicolas W. Shammas, MD, MS, FSCAI
Midwest Cardiovascular Research Foundation
Davenport, IA

Mitchell J. Silver, DO, FSVM
OhioHealth and Riverside Methodist Hospital
Columbus, OH

The conference is being held October 9-12, 2014

Location

The Swisstel
323 East Upper Wacker Drive
Chicago, IL 60601-9722

Media may apply for registration by emailing jromero@crf.org.


'/>"/>
Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Related medicine news :

1. Preliminary Test Points to Ricin Poison in Letter to Obama
2. TA-65 Teloomerase Activator Health and Longevity Benefits - Preliminary Results of TA-65 User's Survey
3. TCT 2014 agenda now available
4. Countdown to 2015 and beyond: Fulfilling the health agenda for women and children
5. Setting the agenda for firearm injury research
6. Live Primary Care CME (Continuing Medical Education) Faculty and Agenda Announced for Presidents' Week Conference in February 2014 to Be Held in Maui, Hawaii
7. Self-rated health puts aging and health needs on the agenda
8. Agenda for Sept. 18 Health Insurance Exchange Virtual Conference Includes Sessions on Exchange Readiness, Call Service Centers
9. Atlantic Information Services Releases Full Agenda for Oct. 8 Virtual Conference on Dual-Eligible Programs Implementation
10. Agenda Announced for the BioTechniques 2013 Virtual Symposium on Exploring the Modern Lab
11. Lucian Leape Institute at the National Patient Safety Foundation Announces Agenda for 6th Annual Forum & Gala
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 2016 , ... W.S. Badger Co. Inc ., the maker of certified ... as one of the best small businesses for new dads by Fatherly, the digital ... businesses providing progressive benefits to new parents on the organization’s 2016 Best Places ...
(Date:5/27/2016)... ... May 27, 2016 , ... An educational campaign aimed at ... stories, courtesy of awareness-driven celebrities and thought leaders. It also provides insight to ... industry leaders such as Bioness. , As patients feel increasingly concerned about ...
(Date:5/27/2016)... ... 27, 2016 , ... Aimed at nurses and employees in the health care ... leaders in the nursing and health care industry. It also provides insight to the ... University. , As the nursing industry is coming out of one of the ...
(Date:5/26/2016)... ... , ... There are many ways to cook a hot dog, but new ... prefer their dogs straight off the grill. Of the 90 percent of Americans who ... cook a hot dog, far outpacing other cooking methods such as steaming (12 percent), ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... property (IP) to its specialty academic programs. , Answering to the increasing demand ... certificate programs in health law, and environmental and land use law. ,  , ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25, 2016 MedDay, a ... announces that an oral presentation entitled "High doses of biotin ... trial" will be given by Professor Ayman Tourbah , ... Congress of the European Academy of Neurology (EAN) in ... related disorders 3" will take place on Sunday, 29 May ...
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und ... Überlegenheit in ‚ausgezeichneter plus guter ... Colons    ,      (Logo: ... gab heute neue positive Daten von der MORA-Studie ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology: